Magazine · Sep 2026
This list names thirty people whose work is changing how health technology gets built, bought, and used. The mix includes founders and CEOs of platforms that sit in daily clinical or administrative workflows, academics and researchers who shape how medical AI is evaluated, and investors who have backed enough of the category to move what gets funded next.
We ranked for influence on healthcare technology, not for media fame alone. Celebrity clinicians who mainly endorse apps without a clear technology footprint are out of scope. Customer-success executives at a single EHR vendor are out of scope unless their work clearly changed the wider market. Inclusion is editorial. Nobody paid for a place on this list, and a company review on Healthcare Industry Reviews does not guarantee a person appears here.
Photos prefer official or press portraits. Where we could not verify a usable public headshot, we use an initials placeholder rather than invent a face.
Founder and CEO, Epic Systems
Epic remains the default clinical system for large U.S. health systems, so her product and partnership choices still set the integration bar for almost every other vendor.
Founder and Director, Scripps Research Translational Institute
His writing and research remain the most widely read public frame for how clinicians should judge AI tools before they reach the ward.
Co-founder and CEO, Abridge
Abridge moved ambient clinical documentation from specialty pilots into Epic-centered enterprise budgets with measurable note workflow claims.
General Partner, Andreessen Horowitz (a16z Bio + Health)
She has backed a dense set of healthcare AI and infrastructure companies that now show up in hospital and ambulatory buying cycles.
Co-founder and CEO, Viz.ai
Viz.ai turned time-sensitive care coordination AI into a deployed hospital workflow, starting with stroke and expanding across specialty pathways.
Co-founder and CEO, Aledade
Aledade scaled technology-enabled value-based care support across thousands of independent primary care practices.
Associate Professor of Biomedical Informatics, Harvard Medical School
His lab's imaging benchmarks and clinician-AI studies still define how medical AI papers get judged for reliability.
Co-founder and CEO, Doximity
Doximity is the professional network most U.S. physicians already use, which makes it a distribution layer for hiring, education, and telehealth adjacency.
Professor of AI and Health; AI Faculty Lead, MIT Jameel Clinic
Her clinical AI and drug-discovery machine learning work set research standards that hospitals and life sciences buyers still cite.
Co-founder and CEO, Innovaccer
Innovaccer's data platform became a common spine for population health and value-based care operations across large provider organizations.
General Partner, Andreessen Horowitz (a16z Bio + Health)
As a physician-investor she sits on boards across biotech and care delivery, shaping which clinical and software bets get multi-year capital.
Co-founder and CEO, Elation Health
Elation built a primary-care-first EHR that thousands of ambulatory clinicians use as their daily clinical system, not a billing afterthought.
Co-founder and CEO, Aidoc
Aidoc scaled radiology AI triage across large hospital networks and made always-on imaging alerts an operations question rather than a research project.
Co-founder and CEO, ArteraAI
ArteraAI brought AI-personalized cancer therapy guidance into guideline and reimbursement settings that most medical AI products never reach.
Partner, Bessemer Venture Partners
His healthcare SaaS investing and published benchmarks shaped how a generation of digital health companies measure growth and go-to-market.
Co-founder and CEO, Phreesia
Phreesia made digital intake and payment capture a default front-door workflow for a large share of ambulatory practices.
Professor; Co-director, Stanford University; Stanford Institute for Human-Centered AI
Her computer vision research and human-centered AI leadership still underpin how medical imaging AI labs train talent and frame risk.
Co-founder and CEO, Nabla
Nabla pushed ambient clinical AI with a clear ambulatory product story and a serious European-to-U.S. commercialization path.
Founder, Rock Health
Rock Health became the early-stage digital health network many founders and health system innovators still use as a shared map of the market.
Co-founder and CEO, Prenosis
Prenosis advanced FDA-authorized AI diagnostics for sepsis risk and pushed precision diagnostics into mainstream health recognition.
Co-founder and CEO, Hinge Health
Hinge Health scaled digital musculoskeletal care into a major employer and health-plan category and took the company public.
Co-founder and CEO, Spring Health
Spring Health built employer mental health benefits infrastructure that large companies now treat as a core benefits product line.
Chief Health AI Officer; Associate Professor, UC San Diego Health; UC San Diego
He leads health-system AI governance as a practicing informatician, which is where enterprise AI projects actually get approved or blocked.
Professor of Medicine; Chief Data Scientist, Stanford University; Stanford Health Care
His work on evaluating clinical AI with real health system data shaped how academic medical centers pressure-test vendor claims.
Partner, Andreessen Horowitz (a16z Bio + Health)
He is one of the more active public investors translating healthcare AI product trends into financing decisions founders and buyers both hear.
Co-founder and CEO, Ambience Healthcare
Ambience built an ambient documentation stack aimed at health system workflows and became a reference competitor in enterprise ambient RFPs.
Co-founder and CEO, Hims & Hers Health
Hims & Hers turned consumer telehealth and specialty medication access into a scaled public company that reshaped online care expectations.
Chief Health AI Transformation Officer; Professor, University of Utah Health
He translates interoperable EHR apps and health system AI strategy into deployed tools, not only papers.
Chair, Department of Biomedical Informatics, Harvard Medical School
As chair of Harvard DBMI he shapes the research agenda and talent pipeline for clinical AI and biomedical informatics.
Managing Director, Flare Capital Partners
Flare Capital's healthcare technology investing helped define the seed-to-growth path for many clinical and payer infrastructure companies.
HIR Voices lists are editorial opinion. Scores and company reviews on this site remain separate judgments. Published Sep 24, 2026.